Curaleaf Holdings (CURLF) Common Equity (2019 - 2026)

Curaleaf Holdings (CURLF) posted quarterly Common Equity of $69.8 million for Q1 2026, up 214.31% year-on-year from $22.2 million in Q1 2025, and down 90.77% on a QoQ basis from $756.3 million in Q4 2025.

Curaleaf Holdings (CURLF) Common Equity (2019 - 2026) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Common Equity for 8 consecutive years, with $69.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Common Equity rose 214.31% year-over-year to $69.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.8 million (up 214.31% YoY) and the FY2025 annual result came in at $756.3 million, down 12.18% from the prior year.
  • Common Equity declined to $69.8 million in Q1 2026 per CURLF's latest filing, from $756.3 million in the prior quarter.
  • Over the last five years, Common Equity for CURLF reached as high as $1805.5 billion in Q1 2022 and fell as low as -$171.3 million in Q3 2025.
  • A 5-year average of $106.9 billion and a median of $958.9 million in 2024 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2022 — Common Equity jumped 112316.97% — and 2025, when it slumped 117.86%.
  • Year by year, Common Equity stood at $1.3 billion in 2022, then dropped by 17.9% to $1.1 billion in 2023, then fell by 18.03% to $861.2 million in 2024, then decreased by 12.18% to $756.3 million in 2025, then plunged by 90.77% to $69.8 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $69.8 million, $756.3 million, and -$171.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.23 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.90 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 56.13 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.50 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn 69.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 69.80 Mn
Dec 31, 2025 756.35 Mn
Sep 30, 2025 -171.25 Mn
Jun 30, 2025 -114.22 Mn
Mar 31, 2025 -61.06 Mn
Dec 31, 2024 861.21 Mn
Sep 30, 2024 958.92 Mn
Jun 30, 2024 992.84 Mn
Mar 31, 2024 -48.31 Mn
Dec 31, 2023 1.05 Bn
Sep 30, 2023 1.09 Bn
Jun 30, 2023 1.18 Bn
Mar 31, 2023 -54.38 Mn
Dec 31, 2022 1.28 Bn
Sep 30, 2022 1.71 Bn
Jun 30, 2022 1.78 Bn
Mar 31, 2022 1,805.54 Bn
Dec 31, 2021 1.55 Bn
Sep 30, 2021 1.76 Bn
Jun 30, 2021 1.81 Bn